Press enter or spacebar to select a desired language.

RSS Items

261 - 270 of 644 results found

More Good News about PCSK9 Inhibitors

Description
In the VESALIUS-VC trial, the PCSK9 inhibitor evolocumab reduced cardiovascular events in very-high-risk patients without prior MI or stroke.